{
    "clinical_study": {
        "@rank": "26731", 
        "acronym": "CUSTOM-DBS", 
        "arm_group": [
            {
                "arm_group_label": "Short PW", 
                "arm_group_type": "Experimental", 
                "description": "Patients with a Vercise DBS system programmed to 30 microseconds pulse width"
            }, 
            {
                "arm_group_label": "Conventional PW", 
                "arm_group_type": "Experimental", 
                "description": "Patients with a Vercise DBS system programmed to 60 microseconds pulse width"
            }, 
            {
                "arm_group_label": "Ventral current steering", 
                "arm_group_type": "Experimental", 
                "description": "Patients with a Vercise DBS system programmed to steer current ventrally"
            }, 
            {
                "arm_group_label": "Dorsal current steering", 
                "arm_group_type": "Experimental", 
                "description": "Patients with a Vercise DBS system programmed to steer current dorsally."
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of the study is to compare different deep brain stimulation (DBS) settings\n      using the commercially approved Boston Scientific Neuromodulation Vercise system."
        }, 
        "brief_title": "CUSTOM-DBS: Current Steering to Optimize Deep Brain Stimulation", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Parkinson's Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "detailed_description": {
            "textblock": "The study is a prospective, multi-center, double-blind, randomized controlled trial.\n\n      This study will compare various program settings for the bilateral stimulation of the STN\n      using the BSC implantable Vercise\u2122 DBS System for the treatment of levodopa-responsive,\n      moderate to severe idiopathic PD."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Implanted bilaterally in STN with a Vercise DBS system for Parkinson's disease for at\n             least three months with programming optimized according to standard of care.\n\n          -  UPDRS subset III score of \u226530 in the in the pre-operative meds off state.\n\n          -  DBS must improve PD symptoms by \u226530% in the meds off state, as measured by UPDRS\n             subset III score.\n\n          -  Medical and mental fitness to comply with programming visit and study related\n             procedures.\n\n          -  Able to understand the study requirements and the treatment procedures and provides\n             written informed consent before any study-specific tests or procedures are performed.\n\n          -  Off symptom rigidity score of \u22652 in the evaluated arm as determined by the UPDRS-III.\n\n        Exclusion Criteria:\n\n          -  Have any significant medical condition that is likely to interfere with study\n             procedures or likely to confound evaluation of study endpoints, including any\n             terminal illness with survival <12 months.\n\n          -  Resting and/or action tremor score of \u22653 on the evaluated side as determined by the\n             UPDRS-III in pre-operative meds off condition."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01896115", 
            "org_study_id": "A4009", 
            "secondary_id": "CDM00060272"
        }, 
        "intervention": {
            "arm_group_label": [
                "Short PW", 
                "Conventional PW", 
                "Ventral current steering", 
                "Dorsal current steering"
            ], 
            "description": "Deep brain stimulation set at short pulse width and monopolar stimulation using current steering", 
            "intervention_name": "Vercise DBS settings", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Stimulation, implantable pulse generator, deep brain stimulation", 
        "lastchanged_date": "November 5, 2013", 
        "location": [
            {
                "contact": {
                    "email": "BSNClinicalTrials@bsci.com", 
                    "phone": "855-213-9890"
                }, 
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91355"
                    }, 
                    "name": "Boston Scientific Clinical Research Information toll free number"
                }, 
                "investigator": {
                    "last_name": "Jens Volkmann, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wurzburg", 
                        "country": "Germany"
                    }, 
                    "name": "Universitat Wurzburg"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Germany"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "Current Steering to Optimize Deep Brain Stimulation", 
        "other_outcome": [
            {
                "description": "Amplitude (mA) difference between full rigidity control threshold and first stimulation induced side effect threshold at current steering settings (current divided 50% between adjacent electrodes).", 
                "measure": "Current Steering therapeutic window", 
                "safety_issue": "No", 
                "time_frame": "Day 1 programming visit"
            }, 
            {
                "description": "Motor function (UPDRS III) at current steering settings", 
                "measure": "Current steering motor function", 
                "safety_issue": "No", 
                "time_frame": "Day 1 programming visit"
            }, 
            {
                "description": "Severity of bradykinesia at 60 \u00b5s, 30 \u00b5s, and current steering settings, at efficacy threshold for rigidity.", 
                "measure": "Current steering on bradykinesia", 
                "safety_issue": "No", 
                "time_frame": "Day 1 programming visit"
            }, 
            {
                "description": "Severity of tremor at rest at 60 \u00b5s, 30 \u00b5s, and current steering settings, at efficacy threshold for rigidity.", 
                "measure": "Current steering on tremor", 
                "safety_issue": "No", 
                "time_frame": "Day 1 programming visit"
            }, 
            {
                "description": "Electrode impedances at beginning and end of programming session", 
                "measure": "Impedances", 
                "safety_issue": "No", 
                "time_frame": "Day 1 programming visit"
            }
        ], 
        "overall_contact": {
            "email": "manolal@bsci.com", 
            "last_name": "Ljubomir Manola", 
            "phone": "011-32-241-672-19"
        }, 
        "overall_contact_backup": {
            "email": "Diane.Bowers@bsci.com", 
            "last_name": "Diane Bowers", 
            "phone": "661-949-4175"
        }, 
        "overall_official": {
            "affiliation": "Boston Scientific Corporation", 
            "last_name": "Stephen Carcieri, Ph.D.", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Amplitude (mA) difference between full rigidity control threshold and first stimulation induced side effect threshold (eye deviation, muscle contraction, and speech), i.e. \"therapeutic window\", at 60 \u00b5s and 30 \u00b5s pulse width DBS settings (measured in mA)", 
                "measure": "Therapeutic window", 
                "safety_issue": "No", 
                "time_frame": "Day 1 programming visit"
            }, 
            {
                "description": "Motor function at 60 \u00b5s and 30 \u00b5s pulse width DBS settings (measured as UPDRS III score).", 
                "measure": "UPDRS III", 
                "safety_issue": "No", 
                "time_frame": "Day 1 programming visit"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01896115"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Boston Scientific Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boston Scientific Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}